Chaihu Shugan San ameliorated cognitive deficits through regulating gut microbiota in senescence-accelerated mouse prone 8

Chaihu Shugan San ameliorated cognitive deficits through regulating gut microbiota in senescence-accelerated mouse prone 8

Background: Traditional Chinese medicines exhibit promising preventive effects on Alzheimer’s disease. Chaihu Shugan San (CSS) is a well-known traditional herbal formula whose several kinds of ingredients have the potential of ameliorating Alzheimer’s disease. The present study aimed to evaluate the...

Full description

Bibliographic Details
Main Authors:	Zhiyue Li, Qiang Zeng, Shengquan Hu, Zhanyan Liu, Shuting Wang, Yu Jin, Limin Li, Hanlin Ou, Zhengzhi Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Pharmacology
Subjects:	mild cognitive impairment gut microbiota neural injury Chaihu Shugan San senescence-accelerated mouse prone 8
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1181226/full

Similar Items

Chaihu-Shugan-San ameliorates tumor growth in prostate cancer promoted by depression via modulating sphingolipid and glycerinphospholipid metabolism
by: Wei Li, et al.
Published: (2022-12-01)

Chaihu-Shugan-San Ameliorated Osteoporosis of Mice with Depressive Behavior Caused by Chronic Unpredictable Mild Stress via Repressing Neuroinflammation and HPA Activity
by: He MC, et al.
Published: (2024-12-01)

Potential antidepressant effects of Traditional Chinese botanical drug formula Chaihu-Shugan-San and its active ingredients
by: Ziyi Guo, et al.
Published: (2024-04-01)

Reporting quality and risk of bias assessment of animal research on Chaihu-Shugan-San for depression: A systematic review
by: Xiao Zhu, et al.
Published: (2023-08-01)

Chaihu-Shugan-San (Shihosogansan) alleviates restraint stress-generated anxiety and depression in mice by regulating NF-κB-mediated BDNF expression through the modulation of gut microbiota
by: Sang-Kap Han, et al.
Published: (2021-08-01)

Mitigating effects of Jiawei Chaihu Shugan decoction on necroptosis and inflammation of hippocampal neurons in epileptic mice
by: Qin Wang, et al.
Published: (2025-02-01)

Chaihu Shugan prevents cholesterol gallstone formation by ameliorating the microbiota dysbiosis and metabolic disturbance in mice
by: Wei Wang, et al.
Published: (2024-01-01)

Proteomics Study Reveals the Anti-Depressive Mechanisms and the Compatibility Advantage of Chaihu-Shugan-San in a Rat Model of Chronic Unpredictable Mild Stress
by: Xiaofei Zhu, et al.
Published: (2022-01-01)

Network Pharmacology and Experimental Evidence: PI3K/AKT Signaling Pathway is Involved in the Antidepressive Roles of Chaihu Shugan San
by: Zhang S, et al.
Published: (2021-08-01)

Chaihu Shugan San and Zuogui Yin synergistically improve premature ovarian failure in a rat model via the PI3K/Akt/mTOR pathway
by: Fei Zhang, et al.
Published: (2025-03-01)

SIRT1/FOXO1 Axis-Mediated Hippocampal Angiogenesis is Involved in the Antidepressant Effect of Chaihu Shugan San
by: Zhang S, et al.
Published: (2022-08-01)

Chaihu-shugan-san alleviates depression-like behavior in mice exposed to chronic unpredictable stress by altering the gut microbiota and levels of the bile acids hyocholic acid and 7-ketoDCA
by: Chong Ma, et al.
Published: (2022-10-01)

A Chinese Classical Prescription Chaihu Shugan Powder in Treatment of Post-Stroke Depression: An Overview
by: Zu Gao, et al.
Published: (2022-12-01)

Chaihu Shugan powder restores fatty acid synthesis to alleviate insulin resistance in metabolic syndrome by regulating the LXRα/SREBP-1 signaling pathway
by: Sisi Lei, et al.
Published: (2024-11-01)

The Modulation of Chaihu Shugan Formula on Microbiota Composition in the Simulator of the Human Intestinal Microbial Ecosystem Technology Platform and its Influence on Gut Barrier and Intestinal Immunity in Caco-2/THP1-Blue™ Cell Co-Culture Model
by: Ling Liu, et al.
Published: (2022-03-01)

Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation
by: Sisi Lei, et al.
Published: (2022-09-01)

New Clinical Application of Chaihu Decoction
by: Bo Huang, et al.
Published: (2022-09-01)

Commentary: The Modulation of Chaihu Shugan Formula on Microbiota Composition in the Simulator of the Human Intestinal Microbial Ecosystem Technology Platform and Its Influence on Gut Barrier and Intestinal Immunity in Caco-2/THP1-Blue™ Cell Co-Culture Model
by: Yang Yu, et al.
Published: (2022-06-01)

Chaihu-Shugan-San exerts an antidepressive effect by downregulating miR-124 and releasing inhibition of the MAPK14 and Gria3 signaling pathways
by: Qiong Liu, et al.
Published: (2018-01-01)

Bile duct perfusion of Chaihu Paishi Decoction combined with duodenoscopy in treatment of difficult choledocholithiasis
by: TANG Tengqian, et al.
Published: (2021-02-01)

Mechanism of Shugan Yidan fang, a Chinese herbal formula, in rat model of premature ejaculation
by: Qiang Han, et al.
Published: (2023-10-01)

Chaihu Oral Liquid improves hippocampal neurogenesis and short-term memory defects in adult BTBR autism mice
by: CHEN Mei, et al.
Published: (2022-05-01)

Effect of Tiaoshen Shugan acupuncture on migraine and its influence on hemodynamics
by: ZHANG Li*, XIN Huimin, ZHUANG Xilan, ZHANG Guangfang
Published: (2023-11-01)

Metagenomics and metabolomics analysis to investigate the effect of Shugan decoction on intestinal microbiota in irritable bowel syndrome rats
by: Lu Hang, et al.
Published: (2022-11-01)

Effectiveness of Shugan Jieyu capsules for psychiatric symptoms of epilepsy: a systematic review and meta-analysis
by: Sejin Kim, et al.
Published: (2024-01-01)

Effect of fluoxetine combined with Shugan Jieyu capsule in the treatment of patients with depression and its impact on heart rate variability
by: Zhao Yuanyuan, et al.
Published: (2023-10-01)

Shugan Jieyu Capsule in Post-Stroke Depression Treatment: From Molecules to Systems
by: Meng Zhang, et al.
Published: (2022-01-01)

A network pharmacology and molecular docking approach to reveal the mechanism of Chaihu Anxin Capsule in depression
by: Lin Yang, et al.
Published: (2023-09-01)

The efficacy of Da Chaihu decoction combined with metformin tablets for type 2 diabetes mellitus: A systematic review and meta-analysis
by: Jia-bin Wang, et al.
Published: (2022-12-01)

Mechanism investigation of anti-NAFLD of Shugan Yipi Granule based on network pharmacology analysis and experimental verification
by: Hairong Li, et al.
Published: (2024-08-01)

The pharmacological mechanism of chaihu-jia-longgu-muli-tang for treating depression: integrated meta-analysis and network pharmacology analysis
by: Yang Zhao, et al.
Published: (2023-09-01)

Chaihu Guizhi Ganjiang Decoction Ameliorates Pancreatic Fibrosis via JNK/mTOR Signaling Pathway
by: Lihua Cui, et al.
Published: (2021-06-01)

Chaihu-Guizhi-Ganjiang Decoction is more efficacious in treating irritable bowel syndrome than Dicetel according to metabolomics analysis
by: Mingming Li, et al.
Published: (2022-12-01)

Effectiveness of the Shugan Jieyu Capsule against Psychiatric Symptoms in Epilepsy: a protocol for systematic review and meta-analysis
by: Sejin Kim, et al.
Published: (2023-03-01)

Proprietary Medicines Containing Bupleurum chinense DC. (Chaihu) for Depression: Network Meta-Analysis and Network Pharmacology Prediction
by: Qiao-feng Li, et al.
Published: (2022-04-01)

Unveiling the Mechanism of the ChaiShao Shugan Formula Against Triple-Negative Breast Cancer
by: Fan T, et al.
Published: (2024-04-01)

Chaihu-Longgu-Muli decoction improves sleep disorders by restoring orexin-A function in CKD mice
by: Xin-li Cao, et al.
Published: (2023-06-01)

Study on the mechanism of Shugan Lidan Xiaoshi granule in preventing acute pancreatitis based on network pharmacology and molecular docking
by: Jiaxing Wang, et al.
Published: (2024-03-01)

Shugan Decoction Alleviates Colonic Dysmotility in Female SERT-Knockout Rats by Decreasing M3 Receptor Expression
by: Yinshu Wang, et al.
Published: (2020-09-01)

Study on the Mechanism of Shugan Xiaozhi Fang on Cells with Non-alcoholic Fatty Liver Disease
by: Xing Yufeng, et al.
Published: (2019-12-01)